|
PGM3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63935531816151E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.2030155477637E-12 |
| Normal-vs-Stage2 |
7.014900E-04 |
| Normal-vs-Stage3 |
6.32320000026887E-07 |
| Normal-vs-Stage4 |
2.454700000043E-06 |
| Stage1-vs-Stage2 |
8.120200E-01 |
| Stage1-vs-Stage3 |
6.133200E-01 |
| Stage1-vs-Stage4 |
4.427200E-01 |
| Stage2-vs-Stage3 |
9.069400E-01 |
| Stage2-vs-Stage4 |
4.694200E-01 |
| Stage3-vs-Stage4 |
3.066600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-15 |
| Normal-vs-AfricanAmerican |
2.168000E-01 |
| Normal-vs-Asian |
1.586570E-01 |
| Caucasian-vs-AfricanAmerican |
8.470599999999E-05 |
| Caucasian-vs-Asian |
6.351200E-01 |
| AfricanAmerican-vs-Asian |
3.122000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.51270115825264E-11 |
| Normal-vs-Female |
2.35655939206936E-12 |
| Male-vs-Female |
1.833840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.974300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.10018677396329E-12 |
| Normal-vs-Age(61-80Yrs) |
6.62300214671063E-11 |
| Normal-vs-Age(81-100Yrs) |
2.789600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.861600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.675400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.973400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.911400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.769600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.858000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.57050000004766E-06 |
| Normal-vs-Grade 2 |
1.38300482177556E-11 |
| Normal-vs-Grade 3 |
1.04530051281415E-10 |
| Normal-vs-Grade 4 |
2.444700E-04 |
| Grade 1-vs-Grade 2 |
5.632800E-01 |
| Grade 1-vs-Grade 3 |
5.702400E-01 |
| Grade 1-vs-Grade 4 |
4.624600E-01 |
| Grade 2-vs-Grade 3 |
9.982800E-01 |
| Grade 2-vs-Grade 4 |
7.059800E-01 |
| Grade 3-vs-Grade 4 |
7.153400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
4.88070000004281E-06 |
| ccA subtype-vs-ccB subtype |
1.430330E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7643664307343E-12 |
| Normal-vs-N1 |
5.975700E-02 |
| N0-vs-N1 |
9.167400E-01 |
|
|
